// App-Quantinova.ai

3313 : Genetic Determinants of Plasma Von Willebrand Factor (VWF) and VWF Propeptide Levels

Researchers

Presenter

  • Ayse Bilge Ozel

Principal Investigators

  • David R Siemieniak

  • Jun Z Li

  • David Ginsburg

Medical Centers

  • Life Sciences Institute, Howard Hughes Medical Institute and University of Michigan, Ann Arbor, USA,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Vasodilation dysfunction

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved